Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
US Stock MarketDetailed Quotes
CMRX Chimerix
- 8.500
- -0.010-0.12%
Close Apr 1 16:00 ET
- 8.510
- +0.010+0.12%
Post 19:07 ET
797.33MMarket Cap-8.59P/E (TTM)
8.510High8.500Low1.75MVolume8.500Open8.510Pre Close14.86MTurnover2.22%Turnover RatioLossP/E (Static)93.80MShares8.53052wk High6.55P/B669.27MFloat Cap0.75052wk Low--Dividend TTM78.74MShs Float58.040Historical High--Div YieldTTM0.12%Amplitude0.750Historical Low8.505Avg Price1Lot Size
Chimerix Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -8.52%-74.98M | -32.08%-19.27M | -14.36%-20.51M | -23.30%-17.68M | 21.18%-17.52M | -47.41%-69.09M | 27.02%-14.59M | -351.59%-17.93M | -35.81%-14.34M | 5.21%-22.23M |
| Net income from continuing operations | -7.66%-88.39M | -26.39%-22.95M | 4.62%-22.88M | -11.35%-20.69M | -2.33%-21.87M | -147.68%-82.1M | 13.35%-18.16M | -109.94%-23.99M | 20.85%-18.58M | 13.71%-21.37M |
| Operating gains losses | -112.50%-17K | -300.00%-12K | ---- | ---- | ---- | 100.00%-8K | ---3K | ---- | ---- | ---- |
| Depreciation and amortization | 3.30%94K | 17.39%27K | -8.70%21K | 4.35%24K | 0.00%22K | -7.14%91K | -8.00%23K | -8.00%23K | -4.17%23K | -8.33%22K |
| Other non cash items | 139.78%223K | 304.76%86K | -2.17%45K | 4.65%45K | 2.17%47K | -61.57%93K | -187.50%-42K | -4.17%46K | -14.00%43K | -52.08%46K |
| Change In working capital | 206.89%7.44M | -24.34%2.07M | 416.39%753K | -39.32%1.89M | 185.45%2.72M | 170.81%2.42M | 269.20%2.74M | 97.19%-238K | -66.24%3.11M | -24.53%-3.19M |
| -Change in receivables | -105.12%-53K | 1,300.00%98K | -273.33%-26K | -119.91%-128K | -99.19%3K | 199.62%1.04M | 101.22%7K | 103.21%15K | --643K | --371K |
| -Change in inventory | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Change in prepaid assets | -41.98%2M | 226.70%223K | 263.28%658K | -132.56%-1.17M | 417.01%2.28M | 163.48%3.44M | 95.28%-176K | 84.52%-403K | 86.45%3.58M | 144.01%441K |
| -Change in payables and accrued expense | 367.56%5.49M | -39.79%1.75M | -19.33%121K | 387.18%3.18M | 111.03%441K | -137.30%-2.05M | 8.11%2.91M | 103.50%150K | ---1.11M | ---4M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -8.52%-74.98M | -32.08%-19.27M | -14.36%-20.51M | -23.30%-17.68M | 21.18%-17.52M | -47.41%-69.09M | 27.02%-14.59M | -351.59%-17.93M | -35.81%-14.34M | 5.21%-22.23M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 1.02%71.32M | -28.86%19.97M | 138.48%28.32M | -22.48%14.36M | -28.51%8.68M | 0.80%70.6M | 112.29%28.07M | -95.02%11.87M | 176.43%18.52M | -77.30%12.14M |
| Net PPE purchase and sale | -254.32%-287K | -5,533.33%-163K | -160.00%-26K | -491.67%-71K | 56.45%-27K | -14.08%-81K | 200.00%3K | 86.11%-10K | ---12K | ---62K |
| Net business purchase and sale | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net investment purchase and sale | 1.31%71.6M | -28.28%20.13M | 138.50%28.34M | -22.15%14.43M | -28.65%8.7M | 143.13%70.68M | 112.29%28.07M | 172.76%11.88M | 176.61%18.53M | -77.19%12.2M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 1.02%71.32M | -28.86%19.97M | 138.48%28.32M | -22.48%14.36M | -28.51%8.68M | 0.80%70.6M | 112.29%28.07M | -95.02%11.87M | 176.43%18.52M | -77.30%12.14M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 2,188.64%7.05M | 10,714.52%6.71M | 128.21%178K | -35.48%-42K | 4.52%208K | 102.42%308K | 293.75%62K | -89.97%78K | -181.82%-31K | 101.48%199K |
| Net issuance payments of debt | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net common stock issuance | --6.84M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | 32.04%614K | --12K | 103.67%222K | --2K | 6.18%378K | -68.32%465K | --0 | -86.54%109K | --0 | -45.90%356K |
| Net other financing activities | -154.78%-400K | -329.03%-142K | -41.94%-44K | -41.94%-44K | -8.28%-170K | 18.65%-157K | 293.75%62K | 3.13%-31K | -181.82%-31K | -33.05%-157K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 2,188.64%7.05M | 10,714.52%6.71M | 128.21%178K | -35.48%-42K | 4.52%208K | 102.42%308K | 293.75%62K | -89.97%78K | -181.82%-31K | 101.48%199K |
| Net cash flow | ||||||||||
| Beginning cash position | 7.04%27.66M | 67.48%23.65M | -22.10%15.66M | 19.28%19.03M | 7.04%27.66M | 67.84%25.84M | -94.85%14.12M | -28.44%20.1M | -50.09%15.95M | 67.84%25.84M |
| Current changes in cash | 86.26%3.39M | -45.33%7.4M | 233.54%7.99M | -181.20%-3.37M | 12.70%-8.64M | -82.58%1.82M | 105.45%13.54M | -102.43%-5.98M | 207.16%4.15M | -159.73%-9.89M |
| End cash Position | 12.25%31.05M | 12.25%31.05M | 67.48%23.65M | -22.10%15.66M | 19.28%19.03M | 7.04%27.66M | 7.04%27.66M | -94.85%14.12M | -28.44%20.1M | -50.09%15.95M |
| Free cash flow | -8.80%-75.26M | -33.20%-19.43M | -14.41%-20.53M | -23.69%-17.75M | 21.28%-17.55M | -47.38%-69.18M | 27.01%-14.59M | -354.37%-17.95M | -35.93%-14.35M | 4.95%-22.29M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now